Sequelae of Ebola Virus Disease, Kenema District, Sierra Leone
The DOI matches its Crossref record.
Abstract
To the Editor—Qureshi and colleagues describe problems faced by survivors of Ebola virus disease (EVD) in Guinea [1]. With >27 500 cases of EVD recorded during the ongoing outbreak in West Africa and a variably reported case fatality of approximately 50%, there are likely >13 000 EVD survivors in the region in need of care. To mount the appropriate range of medical and social services, the District Health Management Team, with support from several partners, conducted a rapid survey in Kenema District, one of the hardest hit areas of Sierra Leone. A convenience sample of 81 EVD survivors was surveyed (n = 51 females, n = 30 males) with a median age of 29 years (range: 10–74). All participants reported health and/or social problems since suffering EVD (Figure 1), and 96% reported rejection by their community after hospital discharge, with the majority still too scared to return. There were no significant differences between the sexes or between age groups, although symptoms were generally less frequent in adolescents. Self-reported symptoms in 81 survivors of Ebola virus disease, Kenema District, Sierra Leone, October, 2014. *Percentage calculated using only denominator of relevant sex. Our survey offers the first glimpse into the challenges facing EVD survivors in Sierra Leone, who reported frequent physical and psychosocial sequelae up to at least 4 months after resolution of acute disease. The data were collected from a small nonrandomized convenience sample at a single cross-sectional time point, precluding us from definitely attributing the noted sequelae to EVD. However, our findings are generally consistent with those of Qureshi et al in Guinea, as well as with the only 2 published controlled studies on post-EVD sequelae [2, 3] and other anecdotal reports [4–6]. The survey results were used to quickly establish a clinic for EVD survivors in Kenema, at which >200 survivors have been seen in >250 visits to date. The most common complaints are musculoskeletal pain, visual problems, abdominal and epigastric pain, insomnia, amenorrhea, anxiety, headache, excessive fatigue, and hiccups. Fortunately, many survivors report improvement in their condition over the past months. It appears clear that the needs of EVD survivors in Kenema and throughout the affected areas in West Africa are great. Service provision for this vulnerable group must be prioritized and must address not only medical needs but also the psychosocial and economic hardships that survivors are experiencing. The recently formed Kenema District Ebola Survivors Union will be an important partner in these services. Lastly, more systematic research on EVD survivors is needed to better understand the true frequencies and underlying pathogenesis of the various problems they face to inform best clinical and social management. Financial support. Funding for the survey was provided by the World Health Organization Field Office in Kenema District, Sierra Leone. Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
the PostEboGui Study Group, Keita, M. M., Taverne, B., Sy Savané, S., March, L., Doukoure, M., Sow, M. S., Touré, A., Etard, J. F., Barry, M., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1280-8 · Cited by 100
“Another study, also in Sierra Leone, conducted among 81 people in the Kenema District found depression among 35%, up to 4 months after the ETC discharge [19].”
BackgroundJames, P. B., Wardle, J., Steel, A., & Adams, J. (2020) · BMC Public Health · doi:10.1186/s12889-020-8279-7 · Cited by 72
Metadata
- Authors
- Nanyonga, M., Saidu, J., Ramsay, A., Shindo, N., & Bausch, D. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-08
- Volume
- 62
- Issue
- 1
- Pages
- 125-126
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1650784653
- Cited by
- 58
- References
- 0
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.